Co-Diagnostics Revenue 2017-2023 | CODX
Co-Diagnostics revenue from 2017 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Co-Diagnostics Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $7 |
| 2022 | $34 |
| 2021 | $98 |
| 2020 | $75 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $ |
| Co-Diagnostics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $4 |
| 2023-09-30 | $2 |
| 2023-06-30 | $0 |
| 2023-03-31 | $1 |
| 2022-12-31 | $1 |
| 2022-09-30 | $5 |
| 2022-06-30 | $5 |
| 2022-03-31 | $23 |
| 2021-12-31 | $20 |
| 2021-09-30 | $30 |
| 2021-06-30 | $27 |
| 2021-03-31 | $20 |
| 2020-12-31 | $27 |
| 2020-09-30 | $22 |
| 2020-06-30 | $24 |
| 2020-03-31 | $2 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.036B | $0.007B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.212B | 15.32 |
| Cencora (COR) | United States | $47.337B | 18.89 |
| ICON (ICLR) | Ireland | $24.074B | 23.75 |
| DiDi Global (DIDIY) | China | $22.638B | 0.00 |
| Avantor (AVTR) | United States | $16.482B | 22.71 |
| CochLear (CHEOY) | $13.356B | 0.00 | |
| Viatris (VTRS) | United States | $13.340B | 3.81 |
| Revvity (RVTY) | United States | $12.276B | 21.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.721B | 21.37 |
| Medpace Holdings (MEDP) | United States | $11.598B | 42.15 |
| Solventum (SOLV) | United States | $11.046B | 0.00 |
| Natera (NTRA) | United States | $10.540B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.851B | 51.19 |
| Bausch + Lomb (BLCO) | Canada | $5.032B | 19.35 |
| Doximity (DOCS) | United States | $4.630B | 34.47 |
| Organon (OGN) | United States | $4.566B | 4.42 |
| Sotera Health (SHC) | United States | $3.085B | 15.14 |
| Progyny (PGNY) | United States | $3.064B | 51.42 |
| Surgery Partners (SGRY) | United States | $2.965B | 27.55 |
| Life Times (LTH) | United States | $2.756B | 30.46 |
| GoodRx Holdings (GDRX) | United States | $2.658B | 134.60 |
| Premier (PINC) | United States | $2.491B | 9.12 |
| Teladoc Health (TDOC) | United States | $2.232B | 0.00 |
| Agilon Health (AGL) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.133B | 6.90 |
| BrightSpring Health Services (BTSG) | United States | $1.762B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.444B | 0.00 | |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.964B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.596B | 3.94 |
| Auna S.A (AUNA) | Luxembourg | $0.549B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.507B | 45.96 |
| MultiPlan (MPLN) | United States | $0.475B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| CareDx (CDNA) | United States | $0.418B | 0.00 |
| LifeMD (LFMD) | United States | $0.412B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.356B | 57.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.286B | 3.79 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.249B | 0.00 |
| Sharecare (SHCR) | United States | $0.227B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.119B | 40.00 |
| Oncology Institute (TOI) | United States | $0.091B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.015B | 0.00 | |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |